Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban in elderly Japanese patients with atrial fibrillation treated in one general hospital.

Yamazaki-Nishioka M, Kogiku M, Noda M, Endo S, Takekawa M, Kishi H, Ota M, Notsu Y, Shimizu M, Yamazaki H.

Xenobiotica. 2019 Sep;49(9):1001-1006. doi: 10.1080/00498254.2018.1524188. Epub 2018 Dec 11.

PMID:
30216091
2.

Association of High-Density Lipoprotein Subclasses with Carotid Intima-Media Thickness: Shimane CoHRE Study.

Notsu Y, Yano S, Takeda M, Yamasaki M, Isomura M, Nabika T, Nagai A.

J Atheroscler Thromb. 2018 Jan 1;25(1):42-54. doi: 10.5551/jat.38844. Epub 2017 Apr 27.

3.

Development of a novel immunoassay specific for mouse intact proinsulin.

Imai S, Takahashi T, Naito S, Yamauchi A, Okada C, Notsu Y, Sakikawa I, Hatanaka M, Iwasaki T, Morita A, Fujii I, Yamane S.

Anal Biochem. 2015 Sep 1;484:91-8. doi: 10.1016/j.ab.2015.05.012. Epub 2015 May 28.

4.

Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.

Notsu Y, Yano S, Shibata H, Nagai A, Nabika T.

Atherosclerosis. 2015 Mar;239(1):61-6. doi: 10.1016/j.atherosclerosis.2014.12.030. Epub 2014 Dec 20.

PMID:
25576847
5.

Diversification of endosymbiosis: replacements, co-speciation and promiscuity of bacteriocyte symbionts in weevils.

Toju H, Tanabe AS, Notsu Y, Sota T, Fukatsu T.

ISME J. 2013 Jul;7(7):1378-90. doi: 10.1038/ismej.2013.27. Epub 2013 Feb 28.

6.

Superflares on solar-type stars.

Maehara H, Shibayama T, Notsu S, Notsu Y, Nagao T, Kusaba S, Honda S, Nogami D, Shibata K.

Nature. 2012 May 16;485(7399):478-81. doi: 10.1038/nature11063.

PMID:
22622572
7.

Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus.

Kanazawa I, Yano S, Notsu Y, Yamaguchi T, Nabika T, Sugimoto T.

Clin Endocrinol (Oxf). 2011 Apr;74(4):467-72. doi: 10.1111/j.1365-2265.2010.03946.x.

PMID:
21128993
8.

Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus.

Kanazawa I, Yano S, Yamaguchi T, Notsu Y, Nabika T, Sugimoto T.

Clin Endocrinol (Oxf). 2010 Oct;73(4):463-8. doi: 10.1111/j.1365-2265.2010.03828.x.

PMID:
20550537
9.

Efficacy of Corrected Rapid Turnover Protein Increment Index (CRII) for Early Detection of Improvement of Nutrition Status in Patients with Malnutrition.

Suyama Y, Adachi K, Notsu Y, Satoh E, Nariai Y, Hashimoto Y, Sumi A, Kawaguchi M, Ishimura N.

J Clin Biochem Nutr. 2009 Jul;45(1):44-8. doi: 10.3164/jcbn.08-244. Epub 2009 Jun 30.

10.

Septic shock induced by Lecythophora mutabilis in a patient with mitochondrial encephalomyopathy.

Taniguchi Y, Taketani T, Moriyama H, Moriki S, Nishimura K, Sato E, Notsu Y, Higuchi T, Sugitani Y, Yasuda K, Nagai A, Yamaguchi S, Shibata H, Masuda J.

J Med Microbiol. 2009 Sep;58(Pt 9):1255-8. doi: 10.1099/jmm.0.010678-0. Epub 2009 Jun 15.

PMID:
19528157
11.

Chemoenzymatic synthesis of glycosylated glucagon-like peptide 1: effect of glycosylation on proteolytic resistance and in vivo blood glucose-lowering activity.

Ueda T, Tomita K, Notsu Y, Ito T, Fumoto M, Takakura T, Nagatome H, Takimoto A, Mihara S, Togame H, Kawamoto K, Iwasaki T, Asakura K, Oshima T, Hanasaki K, Nishimura S, Kondo H.

J Am Chem Soc. 2009 May 6;131(17):6237-45. doi: 10.1021/ja900261g.

PMID:
19361194
12.

[Specificity of homogenous assays for the LDL-cholesterol measurement].

Notsu Y, Shibata H, Nagai A.

Rinsho Byori. 2009 Feb;57(2):131-6. Japanese.

PMID:
19317218
13.

Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.

Notsu Y, Nabika T, Bokura H, Suyama Y, Kobayashi S, Yamaguchi S, Masuda J.

Am J Hypertens. 2009 Mar;22(3):257-62. doi: 10.1038/ajh.2008.346. Epub 2008 Dec 4.

PMID:
19057516
14.

Effects of hyperin, isoquercitrin and quercetin on lipopolysaccharide-induced nitrite production in rat peritoneal macrophages.

Lee S, Park HS, Notsu Y, Ban HS, Kim YP, Ishihara K, Hirasawa N, Jung SH, Lee YS, Lim SS, Park EH, Shin KH, Seyama T, Hong J, Ohuchi K.

Phytother Res. 2008 Nov;22(11):1552-6. doi: 10.1002/ptr.2529.

PMID:
18814209
15.

Involvement of cystatin C in pathophysiology of CNS diseases.

Nagai A, Terashima M, Sheikh AM, Notsu Y, Shimode K, Yamaguchi S, Kobayashi S, Kim SU, Masuda J.

Front Biosci. 2008 May 1;13:3470-9. Review.

PMID:
18508448
16.

Sympathetic regulation of the renal functions in rats reciprocally congenic for chromosome 1 blood pressure quantitative trait locus.

Wang T, Nabika T, Notsu Y, Takabatake T.

Hypertens Res. 2008 Mar;31(3):561-8. doi: 10.1291/hypres.31.561.

PMID:
18497477
17.

[HOMA-IR and related clinical parameters].

Notsu Y, Nabika T, Shibata H, Nagai A, Shiwaku K, Masuda J.

Rinsho Byori. 2007 Aug;55(8):737-42. Japanese.

PMID:
17882795
18.

Physicochemical and pharmacokinetic characterization of highly potent recombinant L-methionine gamma-lyase conjugated with polyethylene glycol as an antitumor agent.

Takakura T, Takimoto A, Notsu Y, Yoshida H, Ito T, Nagatome H, Ohno M, Kobayashi Y, Yoshioka T, Inagaki K, Yagi S, Hoffman RM, Esaki N.

Cancer Res. 2006 Mar 1;66(5):2807-14.

19.

High-level expression and bulk crystallization of recombinant L-methionine gamma-lyase, an anticancer agent.

Takakura T, Ito T, Yagi S, Notsu Y, Itakura T, Nakamura T, Inagaki K, Esaki N, Hoffman RM, Takimoto A.

Appl Microbiol Biotechnol. 2006 Mar;70(2):183-92. Epub 2005 Jul 13.

PMID:
16012835
20.

Change in corneal permeability to timolol after laser in situ keratomileusis and photorefractive keratectomy in rabbit.

Hamada N, Amano S, Yamagami S, Araie M, Oshika T, Wada T, Miyai H, Notsu Y.

Jpn J Ophthalmol. 2005 Jan-Feb;49(1):12-4.

PMID:
15692768
21.

Effect of humulus lupulus on gastric secretion in a rat pylorus-ligated model.

Kurasawa T, Chikaraishi Y, Naito A, Toyoda Y, Notsu Y.

Biol Pharm Bull. 2005 Feb;28(2):353-7.

22.

Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs.

Hashimoto T, Igarashi A, Hoshina F, Yamada M, Toyoda Y, Notsu Y, Kohno S.

J Ocul Pharmacol Ther. 2003 Dec;19(6):569-77.

PMID:
14733714
23.

The complete sequence of the rice (Oryza sativa L.) mitochondrial genome: frequent DNA sequence acquisition and loss during the evolution of flowering plants.

Notsu Y, Masood S, Nishikawa T, Kubo N, Akiduki G, Nakazono M, Hirai A, Kadowaki K.

Mol Genet Genomics. 2002 Dec;268(4):434-45. Epub 2002 Nov 1.

PMID:
12471441
24.

Discovery of novel inhibitors of inducible nitric oxide synthase.

Kita Y, Muramoto M, Fujikawa A, Yamazaki T, Notsu Y, Nishimura S.

J Pharm Pharmacol. 2002 Aug;54(8):1141-5.

PMID:
12195831
25.

Mechanism of AVP release and synthesis in chronic salt-loaded rats.

Morita M, Kita Y, Notsu Y.

J Pharm Pharmacol. 2001 Dec;53(12):1703-9.

PMID:
11804401
26.

Expression of arginine vasopressin and vasopressin V1a receptor mRNA in diabetic (db/db) mice.

Morita M, Kita Y, Morikawa N, Iwami M, Notsu Y.

Exp Clin Endocrinol Diabetes. 2001;109(5):261-6.

PMID:
11507649
27.

Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor.

Masuda J, Nabika T, Notsu Y.

Curr Opin Neurol. 2001 Feb;14(1):77-82. Review.

PMID:
11176221
28.

Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones.

Suzuki A, Yasuno T, Kojo H, Hirosumi J, Mutoh S, Notsu Y.

Jpn J Pharmacol. 2000 Oct;84(2):113-23.

29.

Nonpeptide mimic of bradykinin with long-acting properties.

Aramori I, Zenkoh J, Morikawa N, Asano M, Hatori C, Sawai H, Kayakiri H, Satoh S, Inoue T, Abe Y, Sawada Y, Mizutani T, Inamura N, Iwami M, Nakahara K, Kojo H, Oku T, Notsu Y.

Immunopharmacology. 1999 Dec;45(1-3):185-90.

PMID:
10615010
30.

Evaluation of genetic risk factors for silent brain infarction.

Notsu Y, Nabika T, Park HY, Masuda J, Kobayashi S.

Stroke. 1999 Sep;30(9):1881-6.

PMID:
10471440
31.

Effects of apolipoprotein A gene polymorphisms on lipoprotein (a) concentrations in Japanese.

Park HY, Nabika T, Notsu Y, Kobayashi S, Masuda J.

Clin Exp Pharmacol Physiol. 1999 Apr;26(4):304-8.

PMID:
10225140
32.

Biochemical and pharmacological characterization of FR134043, a novel elastase inhibitor.

Shinguh Y, Yamazaki A, Inamura N, Fujie K, Okamoto M, Nakahara K, Notsu Y, Okuhara M, Ono T.

Eur J Pharmacol. 1998 Mar 26;345(3):299-308.

PMID:
9592030
33.

Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.

Aramori I, Zenkoh J, Morikawa N, Asano M, Hatori C, Sawai H, Kayakiri H, Satoh S, Inoue T, Abe Y, Sawada Y, Mizutani T, Inamura N, Nakahara K, Kojo H, Oku T, Notsu Y.

Mol Pharmacol. 1997 Jul;52(1):16-20.

PMID:
9224807
34.

FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates.

Nakayama O, Hirosumi J, Chida N, Takahashi S, Sawada K, Kojo H, Notsu Y.

Prostate. 1997 Jun 1;31(4):241-9.

PMID:
9180934
35.

Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.

Aramori I, Zenkoh J, Morikawa N, O'Donnell N, Asano M, Nakamura K, Iwami M, Kojo H, Notsu Y.

Mol Pharmacol. 1997 Feb;51(2):171-6.

PMID:
9203620
36.

[Apo(a) phenotype as a risk factor for the silent brain infarction].

Notsu Y, Nabika T, Masuda J, Kobayashi S.

Rinsho Byori. 1997 Feb;45(2):122-6. Japanese.

PMID:
9120995
37.

Effects of FR145237, an acyl-CoA:cholesterol acyltransferase inhibitor, on diet-induced hypercholesterolemia in diabetic rats.

Sakuma Y, Hagihara H, Nagayoshi A, Ohne K, Mutoh S, Ito Y, Nakahara K, Notsu Y, Okuhara M.

Life Sci. 1997;60(6):351-6.

PMID:
9031680
38.
39.

Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat.

Sakuma Y, Hagihara H, Ohne K, Nagayoshi A, Mutoh S, Ito Y, Notsu Y, Okuhara M.

Jpn J Pharmacol. 1996 Jan;70(1):35-41.

40.

Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.

Kojo H, Nakayama O, Hirosumi J, Chida N, Notsu Y, Okuhara M.

Mol Pharmacol. 1995 Sep;48(3):401-6.

PMID:
7565619
41.

FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates.

Hirosumi J, Nakayama O, Chida N, Inami M, Fagan T, Sawada K, Shigematsu S, Kojo H, Notsu Y, Okuhara M.

J Steroid Biochem Mol Biol. 1995 Apr;52(4):365-73.

PMID:
7734405
42.

FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes.

Hirosumi J, Nakayama O, Fagan T, Sawada K, Chida N, Inami M, Takahashi S, Kojo H, Notsu Y, Okuhara M.

J Steroid Biochem Mol Biol. 1995 Apr;52(4):357-63.

PMID:
7734404
43.

Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors.

Aramori I, Morikawa N, Zenkoh J, O'Donnell N, Iwami M, Kojo H, Notsu Y, Okuhara M, Ono S, Nakanishi S.

Eur J Pharmacol. 1994 Oct 14;269(2):277-81.

PMID:
7531648
44.

Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation.

Yokota Y, Inamura N, Asano M, Yamamoto Y, Nakahara K, Notsu Y, Ono T, Watanabe M.

Eur J Pharmacol. 1994 Jun 13;258(3):239-46.

PMID:
8088357
45.

The pharmacological characterization of FK 739, a new angiotensin II-receptor antagonist.

Hamada K, Nakajima Y, Nirei H, Nakajima C, Nagashima A, Sogabe K, Notsu Y, Ono T.

Jpn J Pharmacol. 1993 Nov;63(3):335-43.

46.

Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.

Sogabe K, Nirei H, Shoubo M, Nomoto A, Ao S, Notsu Y, Ono T.

J Pharmacol Exp Ther. 1993 Mar;264(3):1040-6.

PMID:
8450448
47.

A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs.

Asano M, Imai T, Inoue H, Masunaga T, Inamura N, Yatabe T, Hiroi J, Nakahara K, Notsu Y, Takishima T.

Agents Actions. 1993 Mar;38(3-4):171-7.

PMID:
8213343
48.

Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.

Aramori I, Nirei H, Shoubo M, Sogabe K, Nakamura K, Kojo H, Notsu Y, Ono T, Nakanishi S.

Mol Pharmacol. 1993 Feb;43(2):127-31.

PMID:
8429819
49.

An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs.

Nirei H, Hamada K, Shoubo M, Sogabe K, Notsu Y, Ono T.

Life Sci. 1993;52(23):1869-74.

PMID:
8318117
50.

[Advances in automated amino acid analysis].

Endo J, Notsu Y.

Nihon Rinsho. 1992 Jul;50(7):1509-15. Japanese.

PMID:
1404878

Supplemental Content

Support Center